Greet Hermans

researcher

Greet Hermans is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0001-5340-1500
P1053ResearcherIDE-6234-2018
P1153Scopus author ID20733909600

P734family nameHermansQ27254055
HermansQ27254055
HermansQ27254055
P735given nameGreetQ21342555
GreetQ21342555
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q46895738Acute intracardiac right-to-left shunt in a patient with acute respiratory distress syndrome and shock successfully treated with nitric oxide.
Q34419891Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis
Q43074167Alterations in adipose tissue during critical illness: An adaptive and protective response?
Q38160666Assessment of limb muscle strength in critically ill patients: a systematic review
Q57245084Assessment of quadriceps muscle mass with ultrasound in critically ill patients: intra- and inter-observer agreement and sensitivity
Q37206684Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study
Q24649694Clinical review: Critical illness polyneuropathy and myopathy
Q37521395Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target?
Q26799076Clinical review: intensive care unit acquired weakness
Q33751235Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophages
Q51818904Early exercise in critically ill patients enhances short-term functional recovery.
Q57245243Early versus Late Parenteral Nutrition in Critically Ill Adults
Q46628244Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients
Q53070565Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial.
Q41658784Effects of controlled mechanical ventilation on sepsis-induced diaphragm dysfunction in rats
Q57559938Endogenous Carbon Monoxide Production: A Rare and Detrimental Complication of Extracorporeal Membrane Oxygenation
Q47370440Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 countries (PRoVENT): an international, multicentre, prospective study
Q57559947Extracorporeal Membrane Oxygenation: Experience in an Adult Medical ICU
Q50646686Feasibility of neuromuscular electrical stimulation in critically ill patients.
Q92864497Five-year impact of ICU-acquired neuromuscular complications: a prospective, observational study
Q93086480Five-year mortality and morbidity impact of prolonged versus brief ICU stay: a propensity score matched cohort study
Q57559940Galactomannan in Bronchoalveolar Lavage Fluid
Q44508523Greater diaphragm fatigability in individuals with recurrent low back pain
Q38041037ICU-based rehabilitation and its appropriate metrics
Q34552719Impact of early parenteral nutrition completing enteral nutrition in adult critically ill patients (EPaNIC trial): a study protocol and statistical analysis plan for a randomized controlled trial.
Q36880413Impact of early parenteral nutrition on metabolism and kidney injury
Q34586285Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit
Q41771779Increased duration of mechanical ventilation is associated with decreased diaphragmatic force: a prospective observational study
Q100309393Intensive care unit acquired muscle weakness in COVID-19 patients
Q47976182Intensive care unit-acquired weakness
Q34490623Intensive insulin therapy in the medical ICU.
Q57245228Interobserver agreement of medical research council sum-score and handgrip strength in the intensive care unit
Q24200934Interventions for preventing critical illness polyneuropathy and critical illness myopathy
Q24241368Interventions for preventing critical illness polyneuropathy and critical illness myopathy
Q24243431Interventions for preventing critical illness polyneuropathy and critical illness myopathy
Q46793359Invasive pulmonary aspergillosis in the ICU: reply to Wichmann et al.
Q43631437Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study
Q42244078Lectin pathway of complement activation and relation with clinical complications in critically ill children
Q37666366Metabolic aspects of critical illness polyneuromyopathy
Q51007787Muscle atrophy and preferential loss of myosin in prolonged critically ill patients.
Q38462086Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial
Q46121568Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation
Q41489882Predictive value for weakness and 1-year mortality of screening electrophysiology tests in the ICU.
Q37667505Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness.
Q26741099Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness
Q53116971Recurrent high gastrointestinal bleeds after Belsey Mark IV antireflux procedure.
Q42620035Relationship between Abdominal Pressure, Pulmonary Compliance, and Cardiac Preload in a Porcine Model
Q57245233Reply
Q57245212Role of Disease and Macronutrient Dose in the Randomized Controlled EPaNIC Trial
Q35559316Should we abandon manual muscle strength testing in the ICU?
Q49113819Targeted temperature management and neuroprognostication after cardiac arrest: A survey in Belgium
Q38495305The Molecular Adsorbent Recirculating System in patients with severe liver failure: clinical results at the K.U. Leuven
Q34483183The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.
Q38070220The assessment of inspiratory muscle fatigue in healthy individuals: a systematic review
Q50471445The influence of continuous venovenous renal replacement therapy on the plasma disappearance rate of indocyanine green.
Q39750085The interobserver agreement of handheld dynamometry for muscle strength assessment in critically ill patients
Q90761648The urea-creatinine ratio as a novel biomarker of critical illness-associated catabolism
Q57245299Tight Glucose Control in Critically Ill Adults
Q46420959Usefulness of FDG-PET to diagnose intravascular lymphoma with encephalopathy and renal involvement
Q100513286Weakness in the ICU: the right weight on the right scale
Q57559950pH 48 h After Onset of Extracorporeal Membrane Oxygenation Is an Independent Predictor of Survival in Patients With Respiratory Failure